• Revenue Cycle Management
  • COVID-19
  • Reimbursement
  • Diabetes Awareness Month
  • Risk Management
  • Patient Retention
  • Staffing
  • Medical Economics® 100th Anniversary
  • Coding and documentation
  • Business of Endocrinology
  • Telehealth
  • Physicians Financial News
  • Cybersecurity
  • Cardiovascular Clinical Consult
  • Locum Tenens, brought to you by LocumLife®
  • Weight Management
  • Business of Women's Health
  • Practice Efficiency
  • Finance and Wealth
  • EHRs
  • Remote Patient Monitoring
  • Sponsored Webinars
  • Medical Technology
  • Billing and collections
  • Acute Pain Management
  • Exclusive Content
  • Value-based Care
  • Business of Pediatrics
  • Concierge Medicine 2.0 by Castle Connolly Private Health Partners
  • Practice Growth
  • Concierge Medicine
  • Business of Cardiology
  • Implementing the Topcon Ocular Telehealth Platform
  • Malpractice
  • Influenza
  • Sexual Health
  • Chronic Conditions
  • Technology
  • Legal and Policy
  • Money
  • Opinion
  • Vaccines
  • Practice Management
  • Patient Relations
  • Careers

For Stocks, Line of Least Resistance Is Down


There's no way to accurately predict the direction of the stock market -- it's best to let the actual price and volume provide the clues. For now, it appears the line of least resistance is down from here, though we are expecting a brief attempt to stabilize and rally in the near-term.

This week the Standard & Poor's-500stock index made a technical break of the neckline off a larger head and shoulders distributional top. This pattern began forming in early November 2009.

These types of patterns are widely watched and can often times fail to complete. Last summer, a similar and head and shoulders pattern fooled most technicians by refusing to follow through on the downward trajectory for stock prices. An extremely bullish advance began in July and lasted through the entire year.

A better fundamental case could be made for the market in mid-2009 based on improving economic numbers, along with an extremely low bar for company earnings and revenue expectations.

Contrast that to the current situation. The economic expansion and recovery is much more in question. One example of that can be gleamed from Friday's payroll report: The drop in hours worked suggests that consumer demand is not as strong as was expected and manufacturers do not need to produce beyond the current demand requirements. As a result, inventories may be stockpiling too quickly.

Weekly earnings data also declined, which may be a precursor to further declines in retail sales over the coming weeks.

There is no way to accurately predict the direction of the market. It is always best to let the actual price and volume in the present and most recent days provide the clues. For now, the line of least resistance appears lower from here. However I am expecting a brief attempt to stabilize and rally, which may provide other reset or entry points for increasing some short-term exposure.

This material presented here has been obtained or derived from sources believed to be accurate, but we do not guarantee its accuracy and it may possibly be incomplete and condensed. The opinions expressed are based upon our study and interpretation of available data. This is not a prospectus; no effort on our part with respect to sale or purchase of any securities is intended or implied. Any stock noted herein is not, and should not be construed as a recommendation or rating to buy or sell any security. Such stocks are intended for illustrative purposes only. It is possible that at this date or some subsequent date the officers, directors and/or shareholders of Sierra Capital Investors, Inc and its affiliates may own securities or buy or sell securities mentioned herein or those not so mentioned.

CAN SLIM® and variations are marks of Investor’s Business Daily, Inc. and affiliates (‘IBD’). The CAN SLIM® Certified mark is licensed by IBD only to signify successful completion of IBD’s CAN SLIM® Training program. IBD does not license, review or approve of, and is not responsible or liable for any investment advice or other services provided by the user. The user is not an agent of, sponsored by, affiliated with, or owned by IBD and is not authorized by IBD to make any representations, warranties, or promises.

Related Videos
Victor J. Dzau, MD, gives expert advice
Victor J. Dzau, MD, gives expert advice